This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on ISI (1)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA

JAMA. 2002;288:1579.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The FDA has approved the GlucoWatch G2 Biographer (Cygnus Inc, Redwood City, Calif), a glucose monitoring device, for the detection and assessment of episodes of hyperglycemia and hypoglycemia in children and adolescents aged 7 to 17 years old. The device had been previously approved for the same use in adults.

The Biographer, which is worn like a wristwatch, obtains a glucose sample by periodically applying a very low level of electrical current to the skin. The sample is painlessly extracted into hydrogel disks that contain glucose oxidase, and the resulting hydrogen peroxide reacts on a platinum biosensor to produce an electric signal that is translated into an equivalent blood glucose level.

The safety and effectiveness of the Biographer in a juvenile population was demonstrated in a controlled, 15-hour clinical study with 66 persons aged 7 to 17 years with type 1 diabetes mellitus. The participants were unrestricted in their activities . . . [Full Text of this Article]

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Lower Diabetes Risk with Hormone Replacement Therapy: An Encore for Estrogen?
Wilson
ANN INTERN MED 2003;138:69-70.
FULL TEXT